• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

BIO Protocol and NuDAO Join Forces to Accelerate Decentralized Science Development

user avatar

by Giorgi Kostiuk

2 years ago


BIO Protocol and NuDAO have entered into a partnership aimed at strengthening the decentralized science ecosystem through strategic resource allocation and collaboration.

A Transformative Partnership

A recent press release announced NuDAO's strategic allocation of 6.9% of its treasury to BIO Protocol, highlighting a long-term collaboration to accelerate the decentralized science ecosystem. This partnership combines NuDAO's technological expertise in biotech and AI with BIO Protocol's established DeSci infrastructure.

This strategic partnership demonstrates our confidence in BIO Protocol’s vision and our shared commitment to advancing decentralized science.NuDAO

Key Elements of the Partnership

The partnership includes scientific and technical collaborations: * Joint Development: NuDAO and BIO Protocol will collaborate on significant scientific research initiatives, focusing on IP and NFT development. * Co-Incubation Projects: Both organizations will incubate promising research projects together, providing shared resources and expertise. * Governance: Both entities will actively participate in each other's governance frameworks, promoting collaboration and shared decision-making in DeSci development.

The Role of the CRISPR Token

A key component of the partnership is the integration of NuDAO's CRISPR token, which powers the research ecosystem. CRISPR will gain access to BIO Protocol’s research resources, driving innovation. CRISPR token holders will have the opportunity to participate in key decisions, influencing the future of decentralized science. The collaboration will enhance CRISPR’s position within the broader DeSci network, unlocking opportunities for growth and innovation.

The partnership aims to create a global decentralized research community enabling borderless collaboration. It supports the commercialization of biotech innovations, such as rare disease research and longevity research.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Concerns of an AI Bubble Similar to 2008 Housing Crisis

chest

Concerns about a potential AI bubble are being discussed, drawing comparisons to the 2008 housing crisis and the dot-com bubble.

user avatarZainab Kamara

Rising Treasury Yields Impact Stock and Crypto Markets

chest

The recent surge in US 30-year treasury yields is impacting stock and cryptocurrency markets, leading to increased borrowing costs and a preference for safer investments.

user avatarJacob Williams

AI Companies Destroying Books for Training Data Raises Concerns

chest

AI companies are acquiring and destroying physical books to create training datasets, raising concerns about copyright and the preservation of literary works.

user avatarSon Min-ho

Cryptocurrency Scams Account for Over Half of Cybercrime Losses

chest

A report by the Consumer Federation of America reveals that cryptocurrency scams have led to significant financial losses, with estimates reaching 807 billion.

user avatarAyman Ben Youssef

Zcash Launches Ironwood Upgrade to Enhance Security and Privacy

chest

Zcash has launched the Ironwood upgrade to prevent counterfeit coins from entering circulation and to enhance privacy.

user avatarTando Nkube

Morgan Stanley Boosts Apple Stock Rating

chest

Morgan Stanley has reiterated its buy rating on Apple stock, raising the price target to $364.

user avatarKofi Adjeman

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.